Embera NeuroTherapeutics (Shreveport, LA) a development stage pharmaceutical company focused on treatments for smoking cessation and other addictions, closed a $4.5M Series A financing. Participants include Louisiana Ventures, Louisiana Fund and Themelios Ventures.

Thanx for your patience as we catch-up.